GlassScriptPhysician profile
Frances Tanner
NPI 1841777588
$11,050.20
in general payments reported to CMS, 2019-2025
40 companies · $2,131 in 2025
The $2,131 reported for 2025 was more than what 94% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,704 · 2022: $1,782 · 2023: $2,725 · 2024: $2,709 · 2025: $2,131.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,464 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,464.32 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| United Therapeutics Corporation | $1,176.17 | 2022-2025 | Tyvaso, Tyvaso, Orenitram |
| Pfizer INC. | $1,102.75 | 2021-2025 | |
| Actelion Pharmaceuticals US, INC. | $1,076.07 | 2021-2025 | Uptravi, Opsumit, Opsynvi |
| Amgen INC. | $923.17 | 2021-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $858.01 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $772.98 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $748.65 | 2021-2025 | Verquvo, Winrevair, Capvaxive |
| Boehringer Ingelheim Pharmaceuticals, INC. | $716.26 | 2021-2025 | Jardiance |
| Janssen Pharmaceuticals, INC | $503.78 | 2022-2024 | Xarelto |
| Esperion Therapeutics, INC. | $497.94 | 2021-2025 | Nexletol |
| Boston Scientific Corporation | $436.19 | 2022-2025 | Watchman Flx, Avvigo Guidance System, Rotapro |
| Astrazeneca Pharmaceuticals LP | $344.38 | 2021-2025 | Farxiga |
| Novo Nordisk INC | $342.95 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Biotronik INC. | $204.13 | 2021 | |
| Edwards Lifesciences Corporation | $130.78 | 2023 | Sapien 3 Ultra Resilia |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $120.82 | 2024 | Penumbra System |
| Abbott Laboratories | $90.48 | 2023 | Mitraclip |
| Baxter Healthcare | $88.82 | 2023-2024 | Hillrom - Cardiac Ambulatory Monitor, Hillrom - Carnation Ambulatory Monitor |
| Scpharmaceuticals INC. | $87.10 | 2025 | |
| Amarin Pharma, INC. | $84.57 | 2021-2022 | |
| Philips North America LLC | $84.23 | 2023-2024 | (Ck7) Extended Holter, (Ck4) Mcot |
| Alnylam Pharmaceuticals INC. | $78.32 | 2021-2025 | Amvuttra |
| E.R. Squibb & Sons, L.L.C. | $68.48 | 2021-2023 | Camzyos |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $65.67 | 2021-2025 | Lifevest |
| Daiichi Sankyo INC. | $63.29 | 2023-2025 | Injectafer |
| Kiniksa Pharmaceuticals International, Plc | $59.48 | 2024 | Arcalyst |
| Kiniksa Pharmaceuticals, LTD. | $46.48 | 2022-2023 | Arcalyst |
| Liquidia Technologies, INC. | $32.27 | 2025 | Yutrepia |
| Irhythm Technologies, INC. | $31.83 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Johnson & Johnson Health Care Systems INC. | $30.52 | 2023 | Uptravi, Opsumit |
| Distalmotion US | $23.62 | 2025 | Dexter L6 Robot |
| Sanofi-Aventis U.S. LLC | $23.15 | 2021 | |
| Celgene Corporation | $20.59 | 2025 | Eliquis |
| Shockwave Medical, INC | $18.93 | 2021 | |
| Lexicon Pharmaceuticals, INC. | $17.84 | 2024 | |
| Abiomed | $16.93 | 2024 | |
| Genzyme Corporation | $16.61 | 2022 | |
| Lilly USA, LLC | $15.75 | 2025 | Mounjaro |
| Glaxosmithkline, LLC. | $15.53 | 2025 | Arexvy, Shingrix |
| Kestra Medical Technology Services, INC. | $14.68 | 2025 | Assure Wcd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frances Tanner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.